AR055590A1 - Moduladores del receptor de progesterona cianopirrol - fenil amida y usos de los mismos - Google Patents
Moduladores del receptor de progesterona cianopirrol - fenil amida y usos de los mismosInfo
- Publication number
- AR055590A1 AR055590A1 ARP060103258A ARP060103258A AR055590A1 AR 055590 A1 AR055590 A1 AR 055590A1 AR P060103258 A ARP060103258 A AR P060103258A AR P060103258 A ARP060103258 A AR P060103258A AR 055590 A1 AR055590 A1 AR 055590A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- alkyl
- aryl
- cycloalkyl
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Hematology (AREA)
- Pregnancy & Childbirth (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
Estos compuesto son utiles para la contracepcion y terapia de reemplazo hormonal. Composicion farmacéutica. Reivindicacion 1: Un compuesto que tiene la estructura de la formula (1) o su sal aceptable para uso farmacéutico donde: R1 se selecciona del grupo que consiste en: H, CN, C(O)-alquilo C1-6, C(O)-cicloalquilo C3-8, C(O)-alquilo C1-6 sustituido, C(O)-arilo, C(O)-arilo sustituido, C(O)-heteroarilo, C(O)-heterociclo, C(O)-alquenilo C3-6, C(O)-alquinilo C3-6, C(O)-alquenilo C3-6 sustituido, C(O)-alquinilo C3-6 sustituido, C(O)O-alquilo C1-6, C(O)O-cicloalquilo C3-8, C(O)O-alquilo C1-6 sustituido, C(O)O-arilo, C(O)O-arilo sustituido, C(O)O-heteroarilo, C(O)O-heterociclo, C(O)O-alquenilo C3-6, C(O)O-alquinilo C3-6, C(O)O- alquenilo C3-6 sustituido, C(O)O-alquinilo C3-6 sustituido, C(O)NH-alquilo C1-6, C(O)NH-cicloalquilo C3-8, C(O)N-di-cicloalquilo C3-8, C(O)N-dialquilo C1-6, C(O)N-di-alquilo C1-6 sustituido, C(O)NH-alquilo C1-6 sustituido, C(O)NH-arilo, C(O)N-di- arilo, C(O)NH-arilo sustituido, C(O)N-di-arilo sustituido, C(O)NH-heteroarilo, C(O)N-di-heteroarilo, C(O)NH-heterociclo, C(O)N-di-heterociclo, C(O)NH-alquenilo C3-6, C(O)NH-alquinilo C3-6, C(O)NH-alquenilo C3-6 sustituido, y C(O)NH-alquinilo C3-6 sustituido; o R1 es un grupo de union a una segunda estructura de formula (1) para formar un dímero de formula (1), dicho grupo de union es un grupo C(O); R2 se selecciona del grupo que consiste en H, alquilo C1-6, alquilo C1-6 sustituido y cicloalquilo C3-6; con la condicion de que R1 y R2 no son H; con la condicion de que donde R1 es C(O)arilo sustituido, R2 no es H; con la condicion de que cuando R1 es H y R7 es H, R2 no es alquilo C1-6; R3, R4, R5 y R6 se seleccionan independientemente del grupo que consiste en H, halogeno, alquilo C1-6, alquilo C1-6 sustituido, cicloalquilo C3-6, O-alquilo C1-6, O-alquilo C1-6 sustituido, arilo, heteroarilo, heterociclo, arilo sustituido, heteroarilo sustituido y heterociclo sustituido; y R7 se selecciona del grupo que consiste en H, alquilo C1-6, alquilo C1-6 sustituido, cicloalquilo C3-6 y cicloalquilo C3-6 sustituido.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70400805P | 2005-07-29 | 2005-07-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR055590A1 true AR055590A1 (es) | 2007-08-29 |
Family
ID=37309008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060103258A AR055590A1 (es) | 2005-07-29 | 2006-07-27 | Moduladores del receptor de progesterona cianopirrol - fenil amida y usos de los mismos |
Country Status (13)
Country | Link |
---|---|
US (2) | US7297713B2 (es) |
EP (1) | EP1910284A1 (es) |
JP (1) | JP2009502946A (es) |
CN (1) | CN101233103A (es) |
AR (1) | AR055590A1 (es) |
AU (1) | AU2006275832A1 (es) |
BR (1) | BRPI0614413A2 (es) |
CA (1) | CA2613484A1 (es) |
GT (1) | GT200600335A (es) |
MX (1) | MX2008001337A (es) |
PE (1) | PE20070182A1 (es) |
TW (1) | TW200728274A (es) |
WO (1) | WO2007016211A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20070341A1 (es) * | 2005-07-29 | 2007-04-13 | Wyeth Corp | Derivados de pirrol como moduladores del receptor de progesterona |
PE20070182A1 (es) * | 2005-07-29 | 2007-03-06 | Wyeth Corp | Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona |
TW200848019A (en) * | 2007-03-06 | 2008-12-16 | Wyeth Corp | Aryl sulfonamides useful for modulation of the progesterone receptor |
TW200848021A (en) * | 2007-03-06 | 2008-12-16 | Wyeth Corp | Sulfonylated heterocycles useful for modulation of the progesterone receptor |
CA2710293A1 (en) * | 2007-12-20 | 2009-07-02 | Teva Women's Health, Inc. | Dosage regimens and pharmaceutical compositions and packages for emergency contraception |
BRPI1003661A2 (pt) * | 2010-09-15 | 2013-01-08 | Libbs Farmaceutica Ltda | associaÇço farmacÊutica para tratar e/ou prevenir mioma e/ou endometriose, uso de resveratrol e progestogenio, composiÇço farmacÊutica para tratamento e/ou prevenÇço de mioma e/ou endometriose medicamento para tratamento e/ou prevenÇço de mioma e/ou endometrios, kit e mÉtodo para tratamento e/ou prevenÇço de mioma e/ou endometriose |
WO2014202505A1 (de) | 2013-06-20 | 2014-12-24 | Bayer Cropscience Ag | Arylsulfid- und arylsulfoxid-derivate als akarizide und insektizide |
Family Cites Families (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1051322A (es) | 1967-08-09 | |||
GB1215858A (en) | 1968-05-03 | 1970-12-16 | Merck & Co Inc | Nitroimidazole derivatives |
US4315009A (en) | 1978-01-18 | 1982-02-09 | Imperial Chemical Industries Limited | Antisecretory guanidine derivatives and pharmaceutical compositions containing them |
DE3168754D1 (en) | 1980-07-09 | 1985-03-21 | Beecham Group Plc | Clonidine derivatives useful in the treatment of diarrhoea |
US4680413A (en) | 1986-01-17 | 1987-07-14 | Nippon Soda Co., Ltd. | Process for the production of 3-phenyl-4-cyanopyrroles |
US5310938A (en) | 1987-07-29 | 1994-05-10 | American Cyanamid Company | Substituted arylpyrrole compounds |
US4857651A (en) | 1987-07-29 | 1989-08-15 | American Cyanamid Company | α-(2,3-Di(C1 -C4 alkoxy)ethylamino)-β-cyanostyrene and β-nitrostyrene compounds useful as intermediates in the preparation of insecticidal, acaricidal and nematicidal arylpyrroles and method for the preparation thereof |
US4929634A (en) | 1987-10-23 | 1990-05-29 | American Cyanamid Company | Method of and bait compositions for controlling mollusks |
DE3814057A1 (de) | 1988-04-26 | 1989-11-09 | Heumann Pharma Gmbh & Co | 6-oxo-pyridazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
EP0358047A3 (en) | 1988-09-08 | 1991-05-29 | American Cyanamid Company | Method of controlling phytopathogenic fungi |
GB8903592D0 (en) | 1989-02-16 | 1989-04-05 | Boots Co Plc | Therapeutic agents |
DE69026906T2 (de) | 1989-08-11 | 1996-11-28 | American Cyanamid Co., Wayne, N.J. | Arylpyrrol enthaltende insekticidale, acaricidale und nematicidale Mittel sowie Verfahren zu ihrer Herstellung |
US5328928A (en) | 1990-05-11 | 1994-07-12 | American Cyanamid Company | N-acylated arylpyrroles useful as insecticidal, agents |
EP0484614B1 (en) | 1990-05-11 | 1995-05-24 | American Cyanamid Company | N-acylated arylpyrroles useful as insecticidal, acaricidal, nematicidal and molluscicidal agents |
IN172842B (es) | 1990-05-17 | 1993-12-11 | Boots Pharmaceuticals Limited | |
US5215994A (en) | 1990-09-25 | 1993-06-01 | Fujisawa Pharmaceutical Co., Ltd. | Angiotenin II antagonizing heterocyclic derivatives |
US5210092A (en) | 1990-09-25 | 1993-05-11 | Fujisawa Pharmaceutical Co., Ltd. | Angiotensin ii antagonizing heterocyclic derivatives |
DE4036645A1 (de) | 1990-11-16 | 1992-05-21 | Hoechst Ag | Substituierte azole, verfahren zu deren herstellung, deren enthaltende mittel und deren verwendung |
US5151536A (en) | 1990-12-17 | 1992-09-29 | American Cyanamid Company | Process for the manufacture of pesticidal 1-(alkoxymethyl) pyrrole compounds |
DE4102024A1 (de) | 1991-01-24 | 1992-07-30 | Thomae Gmbh Dr K | Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
US5847006A (en) | 1991-02-08 | 1998-12-08 | Cambridge Neuroscience, Inc. | Therapeutic guanidines |
US5354759A (en) | 1991-09-12 | 1994-10-11 | Fujisawa Pharmaceutical Co., Ltd. | Angiotenin II antagonizing heterocyclic compounds |
GB9201789D0 (en) | 1992-01-28 | 1992-03-11 | Fujisawa Pharmaceutical Co | Heterocyclic derivatives |
WO1993019067A1 (en) | 1991-09-12 | 1993-09-30 | Fujisawa Pharmaceutical Co., Ltd. | Imidazopyridine derivatives as angiotensin ii antagonists |
US5306827A (en) | 1991-12-04 | 1994-04-26 | American Cyanamid Company | Haloalkylthio, -sulfinyl and -sulfonyl arylpyrrole insecticidal and acaricidal agents |
US5284863A (en) | 1991-12-04 | 1994-02-08 | American Cyanamid Company | Haloalkylthio, -sulfinyl and -sulfonyl arylpyrrole fungicidal agents |
GB9202633D0 (en) | 1992-02-07 | 1992-03-25 | Fujisawa Pharmaceutical Co | Heterocyclic derivatives |
GB9217820D0 (en) | 1992-08-21 | 1992-10-07 | Fujisawa Pharmaceutical Co | New use |
US5449789A (en) | 1992-11-30 | 1995-09-12 | American Cyanamid Company | Debrominative chlorination of pyrroles |
US5518891A (en) | 1993-03-25 | 1996-05-21 | Actimed Laboratories, Inc. | Dye forming composition and detection of hydrogen peroxide therewith |
TW283246B (es) * | 1994-02-17 | 1996-08-11 | Mitsubishi Electric Machine | |
WO1995022520A1 (en) | 1994-02-17 | 1995-08-24 | American Home Products Corporation | Substituted biphenyl derivatives as phosphodiesterase inhibitors |
US20010020100A1 (en) | 1994-06-14 | 2001-09-06 | G.D. Searle & Co. | N-substituted-1, 2, 4-triazolone compounds for treatment of cardiovascular disorders |
DE19515177A1 (de) | 1995-04-28 | 1996-10-31 | Cassella Ag | Hydantoinderivate als Zwischenprodukte für pharmazeutische Wirkstoffe |
ATE231501T1 (de) | 1995-05-18 | 2003-02-15 | Altana Pharma Ag | Phenyldihydrobenzofurane |
US5932520A (en) | 1995-05-23 | 1999-08-03 | American Cyanamid Company | Use of pyrrole compounds as antifouling agents |
US6242613B1 (en) | 1996-08-02 | 2001-06-05 | American Cyanamid Co. | Stable arylpyrrole particles, process for their preparation and suspension concentrate compositions comprising them |
IL121430A (en) | 1996-08-02 | 2002-03-10 | American Cyanamid Co | Process for the preparation of arylpyrrole particles in the form of stable crystals and concentrated suspending preparations containing stable arylpyrrole particles, which are a product of the process |
US6541499B1 (en) | 1997-05-01 | 2003-04-01 | Eli Lilly And Company | Antithrombotic agents |
SG72827A1 (en) | 1997-06-23 | 2000-05-23 | Hoffmann La Roche | Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives |
TW460460B (en) | 1997-11-04 | 2001-10-21 | Chugai Pharmaceutical Co Ltd | Heterocyclic compounds having NOS inhibitory activities |
AUPP873799A0 (en) | 1999-02-17 | 1999-03-11 | Fujisawa Pharmaceutical Co., Ltd. | Pyridine compounds |
HUP0201314A3 (en) | 1999-03-26 | 2003-02-28 | Euro Celtique Sa | Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof and pharmaceutical compositions containing them |
DE19918725A1 (de) | 1999-04-24 | 2000-10-26 | Bayer Ag | Substituierte N-Cyano-sulfonsäureanilide |
US6407101B1 (en) | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
US6403629B2 (en) | 2000-05-02 | 2002-06-11 | J.B. Chemical And Pharmaceuticals Limited | Heterocyclic compounds for therapeutic use |
BR0207957A (pt) | 2001-03-09 | 2004-02-25 | Pfizer Prod Inc | Compostos antiinflamatórios de benzimidazol |
JP4130774B2 (ja) | 2001-03-09 | 2008-08-06 | ファイザー・プロダクツ・インク | 抗炎症薬としてのトリアゾロピリジン類 |
ES2247271T3 (es) | 2001-04-04 | 2006-03-01 | Pfizer Products Inc. | Nuevos benzotriazoles como compuestos antiinflamatorios. |
ITBO20010271A1 (it) | 2001-05-08 | 2002-11-08 | Giuseppe Cannazza | Metodo per il trattamento e la prevenzione dei disturbi del sistema nervoso centrale associati ad una alterazione della neurotrasmissione gl |
FR2824827B1 (fr) | 2001-05-17 | 2004-02-13 | Fournier Lab Sa | Nouveaux derives de 5-phenyl-1h-indole antagoniste des recepteurs de l'interleukine-8 |
US6855269B2 (en) | 2001-11-09 | 2005-02-15 | Cytec Technology Corp. | Phenyl ether-substituted hydroxyphenyl triazine ultraviolet light absorbers |
JP2005537228A (ja) | 2002-04-25 | 2005-12-08 | ファルマシア・コーポレーション | ピペリジニル−及びピペラジニル−スルホニルメチルヒドロキサム酸並びにプロテアーゼ阻害剤としてのその使用 |
EP1549635A1 (en) | 2002-09-27 | 2005-07-06 | Janssen Pharmaceutica N.V. | 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases |
WO2004039795A2 (en) | 2002-10-29 | 2004-05-13 | Fujisawa Pharmaceutical Co., Ltd. | Amide compounds for the treatment of hyperlipidemia |
US20060089371A1 (en) | 2002-11-11 | 2006-04-27 | Bayer Healthcare Ag | Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist |
GB0230088D0 (en) | 2002-12-24 | 2003-01-29 | Astrazeneca Ab | Therapeutic agents |
GB0302671D0 (en) | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
CA2515440A1 (fr) | 2003-02-12 | 2004-09-02 | L'oreal | Utilisation d'un inhibiteur de 15-hydroxy prostaglandine deshydrogenase pour favoriser la pigmentation de la peau ou des phaneres |
CN1946716B (zh) * | 2004-04-27 | 2011-12-21 | 惠氏公司 | 含有氰基吡咯的环状氨基甲酸酯和硫代氨基甲酸酯联芳基以及其制备方法 |
GT200500183A (es) * | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
GT200500185A (es) * | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
PE20070404A1 (es) * | 2005-07-29 | 2007-05-10 | Wyeth Corp | Compuestos derivados de cianopirrol-sulfonamida como moduladores del receptor de progesterona |
PE20070341A1 (es) * | 2005-07-29 | 2007-04-13 | Wyeth Corp | Derivados de pirrol como moduladores del receptor de progesterona |
PE20070182A1 (es) * | 2005-07-29 | 2007-03-06 | Wyeth Corp | Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona |
-
2006
- 2006-07-26 PE PE2006000916A patent/PE20070182A1/es not_active Application Discontinuation
- 2006-07-27 GT GT200600335A patent/GT200600335A/es unknown
- 2006-07-27 MX MX2008001337A patent/MX2008001337A/es active IP Right Grant
- 2006-07-27 JP JP2008524135A patent/JP2009502946A/ja not_active Withdrawn
- 2006-07-27 BR BRPI0614413A patent/BRPI0614413A2/pt not_active IP Right Cessation
- 2006-07-27 EP EP06774704A patent/EP1910284A1/en not_active Withdrawn
- 2006-07-27 AR ARP060103258A patent/AR055590A1/es not_active Application Discontinuation
- 2006-07-27 WO PCT/US2006/029124 patent/WO2007016211A1/en active Application Filing
- 2006-07-27 TW TW095127517A patent/TW200728274A/zh unknown
- 2006-07-27 US US11/494,069 patent/US7297713B2/en not_active Expired - Fee Related
- 2006-07-27 CN CNA2006800277569A patent/CN101233103A/zh not_active Withdrawn
- 2006-07-27 AU AU2006275832A patent/AU2006275832A1/en not_active Abandoned
- 2006-07-27 CA CA002613484A patent/CA2613484A1/en not_active Abandoned
-
2007
- 2007-09-12 US US11/900,461 patent/US7652062B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101233103A (zh) | 2008-07-30 |
US20070027125A1 (en) | 2007-02-01 |
AU2006275832A1 (en) | 2007-02-08 |
GT200600335A (es) | 2007-05-28 |
WO2007016211A1 (en) | 2007-02-08 |
BRPI0614413A2 (pt) | 2016-11-22 |
US7297713B2 (en) | 2007-11-20 |
US20080064673A1 (en) | 2008-03-13 |
US7652062B2 (en) | 2010-01-26 |
CA2613484A1 (en) | 2007-02-08 |
JP2009502946A (ja) | 2009-01-29 |
EP1910284A1 (en) | 2008-04-16 |
PE20070182A1 (es) | 2007-03-06 |
TW200728274A (en) | 2007-08-01 |
MX2008001337A (es) | 2008-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR055590A1 (es) | Moduladores del receptor de progesterona cianopirrol - fenil amida y usos de los mismos | |
AR064608A1 (es) | Derivados de pirazolo-quinazolina sustituidos, composiciones farmaceuticas que los contienen. proceso para su preparacion y uso de los mismos como agentes anticancer. | |
PE20220592A1 (es) | Inhibidores de la autofagia de heteroarilaminopirimidina amida y metodos de uso de estos | |
PE20221910A1 (es) | Derivados de pirazolilo utiles como agentes anticancerigenos | |
AR120682A1 (es) | Compuestos de benzotiadiazepina y su uso como moduladores del ácido biliar | |
AR120679A1 (es) | Compuestos de benzoti(di)azepina y su uso como moduladores ácido biliar | |
UY29316A1 (es) | Miméticos de glucocorticoides, métodos para prepararlos, composiciones farmacéuticas, y usos de los mismos. | |
PE20090151A1 (es) | Derivados de pirimidinona y metodos para su uso | |
ECSP066459A (es) | Miméticos de glucocorticoides, métodos de preparación, composiciones farmacéuticas y usos de los mismos | |
AR120674A1 (es) | Compuestos de benzotiazepina y su uso como ácido biliar | |
UY28157A1 (es) | Miméticos de glucocorticoides métodos para su elaboración composiciones farmacéuticas y sus usos | |
AR120683A1 (es) | Compuestos de benzoti(di)azepina y su uso como ácido biliar | |
AR126076A1 (es) | Compuestos de benzotia(di)azepina y su uso como moduladores del ácido biliar | |
BR112022010383A2 (pt) | Compostos tricíclicos substituídos | |
AR043508A1 (es) | 1-amino 1-h-imidazoquinolinas y su uso como inmunomoduladores | |
PE20060555A1 (es) | Derivados de pirrol-oxindol como moduladores del receptor de progesterona | |
AR057380A1 (es) | Compuestos quimicos derivados de 2-azetidinona y uso terapeutico de los mismos | |
AR049706A1 (es) | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
AR047744A1 (es) | Compuestos de triazol y su uso como antagonistas del receptor de glutamato metabotropico | |
AR026122A1 (es) | Derivados de 3(5)-amino-pirazol, procedimiento para su preparacion y su uso como agente antitumorales | |
PE20060691A1 (es) | Serinamidas sustituidas por benzoilo | |
AR033344A1 (es) | Compuestos derivados de benzofenonas como inhibidores de la transcriptasa inversa, su uso en la fabricacion de medicamentos, intermediarios y composiciones farmaceuticas | |
AR060623A1 (es) | Compuestos derivados de 2-azetidinona y un metodo de preparacion | |
AR059176A1 (es) | Compuesto de indol, composicion farmaceutica que lo comprende, metodo para prepararlo y su uso para preparar dicha composicion y para la manufactura de un medicamento para el tratamiento o prevencion de leiomiomas y endometriosis. | |
RU2008123388A (ru) | Соединения и композиции в качестве модуляторов lxr |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |